ClinicalTrials.gov
public full text
Public Domain
Randomized Double Blind Placebo Controlled Clinical Trial to Evaluate Obese and Overweight Subjects
The purpose of the study is to evaluate the effect on weight loss in a group of subjects suffering from overweight and mild obesity (BMI between 25 and 32 Kg/m2) and with weight \> 75 Kg/m2 being administered with a 3 g/day polyglucosamine dosage.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Studying the Effects of Sibutramine on Eating Behavior#801884
- Endocrinological aspects of sarcopenic obesity#4657
- Beta-Cell - Liver Interactions in Situations of Modified Beta-Cell Function#884770
- Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)#812991
- Comparison of Laboratory Changes, Food Intake and Metabolic Profile in Patients With Obesity and Type2 Diabetes Mellitus: Before, During and After Taking AphoelineBrake#172491
Record · ID 868185
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive